Molanic 625 Dry Syrup is effective in urinary tract infections caused by amoxycilling-resistant organisms and in lower respiratory tract infections unresponsive to previous routine antibiotic therapy, in hospitalized Patients.
Exhibits potent broad spectrum of antibacterial activity coverage of bet-lactamase-producing pathogens and a favourable pharmackinetic/ pharmacodynamic profile.
Molanic Dry Syrup enhances the antibacterial spectrum .